4.7 Article

Human T cells efficiently control RSV infection

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

Alberto Papi et al.

Summary: A phase 3 clinical trial showed that a candidate vaccine for respiratory syncytial virus (RSV) infection has a high efficacy in preventing RSV-related respiratory infection and lower respiratory tract disease in older adults. The vaccine was effective against both RSV subtypes and in individuals with underlying conditions.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Immunology

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants

Eric A. F. Simoes et al.

Summary: The study indicates that suptavumab did not reduce the overall rate of childhood RSV respiratory infections due to a newly circulating mutant strain of RSV B. Genetic variation in circulating RSV strains will continue to pose challenges to prevention efforts.

CLINICAL INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Angela Wahl et al.

Summary: The study suggests that bats may be the source of coronaviruses that can be directly transmitted to humans. Using the LoM model, efficient replication of SARS-CoV, MERS-CoV, SARS-CoV-2, and two SARS-like bat coronaviruses in human lung tissue was demonstrated. Infection with SARS-CoV-2 predominantly targets human lung epithelial cells and induces a sustained inflammatory response. The broad-spectrum antiviral agent EIDD-2801 significantly inhibits SARS-CoV-2 replication in vivo, showing potential for prevention and treatment of COVID-19.

NATURE (2021)

Article Immunology

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Maryam Mukhamedova et al.

Summary: The DS-Cav1 vaccine induces a diverse polyclonal response targeting antigenic sites on the pre-F of RSV, supporting the development and advanced testing of pre-F-based vaccines.

IMMUNITY (2021)

Article Medicine, Research & Experimental

Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy

Adrienne E. Swanstrom et al.

Summary: The effectiveness of virus-specific strategies, such as administered HIV-specific mAbs, in targeting cells harboring latent HIV genomes during cART has been limited. Depletion of CD4(+) T cells using anti-CD4 mAb did not significantly delay viral rebound after stopping cART, indicating limited effectiveness in key tissue sites.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Critical Care Medicine

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Tracy J. Ruckwardt et al.

Summary: The study evaluated the safety and immunogenicity of the DS-Cav1 prefusion F subunit vaccine in healthy adults aged 18-50 years. Results showed that DS-Cav1 vaccination was safe, well tolerated, and induced robust and sustained neutralising activity and binding antibodies. Higher vaccine doses or a second immunisation provided a transient advantage, but did not significantly impact long-term neutralisation, indicating that a single low-dose of pre-F immunisation may confer protection throughout an entire RSV season.

LANCET RESPIRATORY MEDICINE (2021)

Review Immunology

In Vitro Modelling of Respiratory Virus Infections in Human Airway Epithelial Cells A Systematic Review

Laurine C. Rijsbergen et al.

Summary: Respiratory tract infections, mainly caused by viruses, are a common cause of morbidity and mortality in humans. In vitro culture models that accurately reflect the human respiratory tract are essential to study virus-host interactions and test novel therapeutic interventions. Recent advances in in vitro models, including primary human airway epithelial cells and human airway organoids, provide new opportunities for research in this field.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Immunology

Respiratory Syncytial Virus Antivirals: Problems and Progress

Frederick G. Hayden et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

Julia Bergild McBrien et al.

NATURE (2020)

Article Biotechnology & Applied Microbiology

Precision mouse models with expanded tropism for human pathogens

Angela Wahl et al.

NATURE BIOTECHNOLOGY (2019)

Article Biochemistry & Molecular Biology

Long-term expanding human airway organoids for disease modeling

Norman Sachs et al.

EMBO JOURNAL (2019)

Review Respiratory System

Use of precision cut lung slices as a translational model for the study of lung biology

Guanghui Liu et al.

RESPIRATORY RESEARCH (2019)

Article Medicine, Research & Experimental

Use of Precision-Cut Lung Slices as an Ex Vivo Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy

Maria C. Rosales Gerpe et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Review Microbiology

Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment

Cameron Griffiths et al.

CLINICAL MICROBIOLOGY REVIEWS (2017)

Article Oncology

CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice

Perry Tsai et al.

MOLECULAR THERAPY-ONCOLYTICS (2016)

Review Infectious Diseases

Host response to respiratory syncytial virus infection

Lourdes Arruvito et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2015)

Article Allergy

Neutrophils in respiratory syncytial virus infection: A target for asthma prevention

Ruben J. Geerdink et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Review Oncology

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis

Raymond J. Pickles et al.

JOURNAL OF PATHOLOGY (2015)

Article Medicine, Research & Experimental

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction

Rachael M. Liesman et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Multidisciplinary Sciences

Visualizing the replication of respiratory syncytial virus in cells and in living mice

Marie-Anne Rameix-Welti et al.

NATURE COMMUNICATIONS (2014)

Article Critical Care Medicine

Relative Respiratory Syncytial Virus Cytopathogenesis in Upper and Lower Respiratory Tract Epithelium

Hong Guo-Parke et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Virology

Protective and dysregulated T cell immunity in RSV infection

Peter J. Openshaw et al.

CURRENT OPINION IN VIROLOGY (2013)

Article Biochemical Research Methods

A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment

Shawn Rose et al.

CYTOMETRY PART A (2012)

Editorial Material Respiratory System

Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner?

R. G. Hegele

EUROPEAN RESPIRATORY JOURNAL (2011)

Review Immunology

Respiratory syncytial virus vaccine development

Julia L. Hurwitz

EXPERT REVIEW OF VACCINES (2011)

Article Critical Care Medicine

Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus

John P. DeVincenzo et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Article Immunology

Murine lung eosinophil activation and chemokine production in allergic airway inflammation

C. Edward Rose et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2010)

Article Immunology

Host immunity during RSV pathogenesis

Susan M. Bueno et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2008)

Article Pathology

The histopathology of fatal untreated human respiratory syncytial virus infection

Joyce E. Johnson et al.

MODERN PATHOLOGY (2007)

Article Biochemistry & Molecular Biology

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

Michael W. Melkus et al.

NATURE MEDICINE (2006)

Article Pediatrics

Neutrophil-mediated inflammation in respiratory syncytial viral bronchiolitis

K Yasui et al.

PEDIATRICS INTERNATIONAL (2005)

Article Pediatrics

Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis

PS McNamara et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2003)

Article Multidisciplinary Sciences

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

EM Janssen et al.

NATURE (2003)